Prostate cancer remains a significant health concern, affecting approximately 1 in 8 men, according to Dr. Phillip Koo, Executive Vice President and Chief Medical Officer at the Prostate Cancer Foundation. In a recent discussion sponsored by Novartis, Dr. Koo and patient advocate Bill, who has lived with prostate cancer for 18 years, emphasized the importance of PSMA testing in guiding treatment decisions and improving outcomes.
Early detection through screening is crucial, and Dr. Koo recommends that men discuss the PSA blood test with their doctors. However, for those already diagnosed, PSMA PET imaging offers a way to determine if cancer has spread. PSMA, or prostate-specific membrane antigen, is a biomarker present in 80-90% of prostate cancer cases, making it a reliable target for imaging.
Bill's journey with PSMA testing began after his diagnosis when he actively sought information. He brought the option to his doctor, and together they incorporated it into his treatment plan. "It helped me understand truly where I am in this journey," Bill said, noting that the scan results empowered him to take an active role in his care. After receiving his results, he and his oncologist crafted a personalized plan, underscoring the value of informed patient-doctor collaboration.
Dr. Koo stressed that patients must speak up and educate themselves. "Knowing your PSMA status is vitally important to your cancer care," he said. The information can guide whether a patient is a candidate for certain therapies, such as PSMA-targeted treatments, and can help avoid unnecessary procedures.
The implications of PSMA testing are far-reaching. For patients, it can mean more accurate staging, better treatment selection, and potentially improved survival. For the healthcare system, it may lead to more cost-effective care by avoiding ineffective treatments. As Dr. Koo noted, the test is vital for determining the next steps in care.
For men with prostate cancer, the call to action is clear: ask your doctor about PSMA testing. More information is available at GetYourScan.com, which provides resources on how to advocate for this important scan.
